A Multicenter, Prospective, Randomized Trial of Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Severity of adverse events as assessed by the WHO
It is difficult to estimate the exact cycles of chemotherapy，we may calculate the rate of complete response and the rate of treatment failure at the preliminary end point of the trail.
Xing Xie, MD, PhD
China: Ministry of Health